📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Step Pharma

1.1 - Company Overview

Step Pharma Logo

Step Pharma

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.

Products and services

  • STP938: Clinical-stage, orally bioavailable CTPS1 inhibitor engineered to block a key nucleotide synthesis step, treating blood cancers and potentially solid tumors
  • CTPS1 Inhibition: Mechanism-based therapeutic approach that targets CTPS1 to inhibit a key nucleotide synthesis step, architected to treat various cancers
  • CTPS1 Inhibition for Blood Cancers: Enzyme-targeted oncology product built to block nucleotide synthesis via CTPS1, delivered specifically for treating blood cancers

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Step Pharma

Tusk Therapeutics Logo

Tusk Therapeutics

HQ: United Kingdom Website
  • Description: Provider of immuno-oncology therapies, discovering and developing unique therapeutic antibodies that harness the immune system to treat cancer, with a growing, diversified pipeline targeting both novel and validated targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tusk Therapeutics company profile →
Quanticel Logo

Quanticel

HQ: United States Website
  • Description: Provider of oncology drug discovery, leveraging a proprietary single-cell genomic analysis platform for human cancer to enable the discovery and development of breakthrough, first-in-class cancer therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quanticel company profile →
Acetylon Logo

Acetylon

HQ: United States Website
  • Description: Provider of small molecule drugs aimed at realizing the therapeutic potential of histone deacetylase; incorporated in 2008 and based in Boston, Massachusetts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acetylon company profile →
GEDiCube Logo

GEDiCube

HQ: The Netherlands Website
  • Description: Provider of AI/ML multi-omics analytics for biomarker discovery, early cancer detection, and treatment monitoring. Offerings include the GEDi Cube platform leveraging epigenomics, transcriptomics, metabolomics, genomics and clinical data; 2600+ biomarker panels for detection and patient stratification; liquid biopsy diagnostics; an explainable AI engine; and non-toxic therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GEDiCube company profile →
Salmedix Logo

Salmedix

HQ: United States Website
  • Description: Provider of oncology drug development focused on hematologic malignancies (blood cancers). Primary product SDX-105 is marketed by healthcare professionals in Germany for several types of blood cancers; conducts Phase II clinical trials for SDX-105 in the U.S. and Canada.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salmedix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Step Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Step Pharma

2.2 - Growth funds investing in similar companies to Step Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Step Pharma

4.2 - Public trading comparable groups for Step Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Step Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Step Pharma

What does Step Pharma do?

Step Pharma is a provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.

Who are Step Pharma's competitors?

Step Pharma's competitors and similar companies include Tusk Therapeutics, Quanticel, Acetylon, GEDiCube, and Salmedix.

Where is Step Pharma headquartered?

Step Pharma is headquartered in France.

How many employees does Step Pharma have?

Step Pharma has 1,000 employees 🔒.

When was Step Pharma founded?

Step Pharma was founded in 2010 🔒.

What sector and industry vertical is Step Pharma in?

Step Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Step Pharma

Who are the top strategic acquirers in Step Pharma's sector and industry

Top strategic M&A buyers and acquirers in Step Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Step Pharma?

Top strategic M&A buyers groups and sectors for Step Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Step Pharma's sector and industry vertical

Which are the top PE firms investing in Step Pharma's sector and industry vertical?

Top PE firms investing in Step Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Step Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Step Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Step Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Step Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Step Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Step Pharma?

The key public trading comparables and valuation benchmarks for Step Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Step Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Step Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Step Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Step Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Step Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Step Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Step Pharma